Ozanimod shows efficacy in two-year study extension
Ozanimod shows efficacy in two-year study extension
Results from the extension period of a Phase II trial, assessing Ozanimod as a potential treatment for relapsing-remitting multiple sclerosis, showed that the drug can effectively and safely improve clinical measures of RRMS after two years of treatment...Read more - http://www.ms-uk.org/ozanimod-shows-eff ... ion-260916
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1285 Views
-
Last post by frodo
-
- 0 Replies
- 9914 Views
-
Last post by NHE
-
- 0 Replies
- 949 Views
-
Last post by frodo
-
- 0 Replies
- 1235 Views
-
Last post by NHE
-
- 0 Replies
- 1945 Views
-
Last post by DIM
-
- 0 Replies
- 1770 Views
-
Last post by DIM
-
- 0 Replies
- 1532 Views
-
Last post by frodo
-
- 0 Replies
- 1883 Views
-
Last post by Tif